OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Anushka Dongre, Robert A. Weinberg
Nature Reviews Molecular Cell Biology (2018) Vol. 20, Iss. 2, pp. 69-84
Closed Access | Times Cited: 3066

Showing 1-25 of 3066 citing articles:

Oxidative Stress in Cancer
John D. Hayes, Albena T. Dinkova‐Kostova, Kenneth D. Tew
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 167-197
Open Access | Times Cited: 1839

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722

Guidelines and definitions for research on epithelial–mesenchymal transition
Jing Yang, Parker B. Antin, Geert Berx, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 6, pp. 341-352
Open Access | Times Cited: 1637

Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan, Yinda Yu, Xiaojian Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1333

EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir, Anna M. Chiarella, Jason R. Pitarresi, et al.
Trends in Cell Biology (2020) Vol. 30, Iss. 10, pp. 764-776
Open Access | Times Cited: 725

Mechanisms of 3D cell migration
Kenneth M. Yamada, Michael Sixt
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 12, pp. 738-752
Closed Access | Times Cited: 724

TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 649

Circulating tumor cells: biology and clinical significance
Danfeng Lin, Lesang Shen, Meng Luo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 619

Interleukins in cancer: from biology to therapy
Daria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 481-499
Open Access | Times Cited: 547

Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 504

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Yuhe Huang, Weiqi Hong, Xiawei Wei
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 416

Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
María Casanova-Acebes, Erica Dalla, Andrew M. Leader, et al.
Nature (2021) Vol. 595, Iss. 7868, pp. 578-584
Open Access | Times Cited: 415

Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert, Robert A. Weinberg
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 325-338
Closed Access | Times Cited: 403

Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Álvaro Quintanal-Villalonga, Joseph M. Chan, Helena A. Yu, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 6, pp. 360-371
Open Access | Times Cited: 399

Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin, Jelena Grahovac, Anamaria Brozović, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100715-100715
Open Access | Times Cited: 389

Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 379

Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams, Dingcheng Gao, Andrew Redfern, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 716-732
Open Access | Times Cited: 374

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Jie Su, Sophie M. Morgani, Charles J. David, et al.
Nature (2020) Vol. 577, Iss. 7791, pp. 566-571
Open Access | Times Cited: 371

Cellular Plasticity in Cancer
Salina Yuan, Robert J. Norgard, Ben Z. Stanger
Cancer Discovery (2019) Vol. 9, Iss. 7, pp. 837-851
Open Access | Times Cited: 368

Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah, Metka Novak, Barbara Breznik
Seminars in Cancer Biology (2019) Vol. 60, pp. 262-273
Open Access | Times Cited: 325

Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng‐Kai Hsu, Chia‐Yang Li, I‐Ling Lin, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8813-8835
Open Access | Times Cited: 315

Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer
Neha M. Akella, Lorela Ciraku, Mauricio J. Reginato
BMC Biology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 305

Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
Nemanja D. Marjanovic, Matan Hofree, Jason E. Chan, et al.
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 229-246.e13
Open Access | Times Cited: 302

Page 1 - Next Page

Scroll to top